Skip to main content
. 2017 Dec 14;22(12):2209. doi: 10.3390/molecules22122209

Figure 3.

Figure 3

The spatial information of cancer cells under the impact of the (a) gefitinib and rosiglitazone; (b) erlotinib and imatinib; (c) gefitinib and quinacrine. The initial drug ratios between these drug pairs are 1:4.